Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group

An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's ch...

Full description

Saved in:
Bibliographic Details
Main Authors Nakazato, Atsuro, Okubo, Taketoshi, Nozawa, Dai, Yamaguchi, Mikako, Tamita, Tomoko, Kennis, Ludo E. J, De Bruyn, Marcel F. L, Bongartz, Jean-Pierre A. M, Van Den Keybus, Frans M. A, Van Roosbroeck, Yves E. M, Luyckx, Marcel G. M, Hendrickx, Robert J. M
Format Patent
LanguageEnglish
Published 26.04.2011
Online AccessGet full text

Cover

More Information
Summary:An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastric diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alopecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, etc. This problem can be solved with a pyrrolopyrimidine or pyrrolopyridine derivative substituted with a cyclic amino group represented by formula [I] below which has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.